中国科学院上海生物化学与细胞生物学研究所博士毕业

华中科技大学药学流动站出站博士后。主要从事肿瘤发病机理及新型生物技术在抗癌药物中的应用研究。

1, Targeting mitosis exit: A brake for cancer cell proliferation. BBA - Reviews on Cancer, 2019;

2, Reducing protein regulator of cytokinesis 1 as a prospective therapy for hepatocellular carcinoma. Cell Death & Disease, 2018;

3, Inhibition of kinesin family member 20B sensitizes hepatocellular carcinoma cell to microtubule‐targeting agents by blocking cytokinesis. Cancer Sci, 2018;

4, MPHOSPH1: a potential therapeutic target for hepatocellular carcinoma. Cancer Res, 2014;

5, Oncogenic role of kinesin proteins and targeting kinesin therapy. Cancer Sci, 2013;

6, Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL. Cancer Gene Ther, 2012；

7, A new oncolytic adenoviral vector carrying dual tumor suppressor genes shows potent antitumor effect. J Cell Mol Med, 2011;

8, Coffee components inhibit amyloid formation of human islet amyloid polypeptide in vitro: possible link between coffee consumption and diabetes mellitus. J Agric Food Chem, 2011;

9, Synergistic antitumor effect of TRAIL and IL-24 with complete eradication of hepatoma in the CTGVT-DG strategy. Acta Biochim Biophys Sin, 2012.